nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2C19—epilepsy syndrome	0.122	0.436	CbGaD
Rosiglitazone—CYP2D6—epilepsy syndrome	0.0905	0.323	CbGaD
Rosiglitazone—ALB—epilepsy syndrome	0.0677	0.242	CbGaD
Rosiglitazone—CYP2A6—Amobarbital—epilepsy syndrome	0.0228	0.0453	CbGbCtD
Rosiglitazone—ALB—Oxcarbazepine—epilepsy syndrome	0.0207	0.041	CbGbCtD
Rosiglitazone—ALB—Fosphenytoin—epilepsy syndrome	0.0181	0.0358	CbGbCtD
Rosiglitazone—CYP2A6—Propofol—epilepsy syndrome	0.017	0.0338	CbGbCtD
Rosiglitazone—ALB—Clonazepam—epilepsy syndrome	0.0163	0.0324	CbGbCtD
Rosiglitazone—CYP2A6—Phenobarbital—epilepsy syndrome	0.0162	0.0323	CbGbCtD
Rosiglitazone—CYP2C8—Trimethadione—epilepsy syndrome	0.0148	0.0295	CbGbCtD
Rosiglitazone—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0139	0.0277	CbGbCtD
Rosiglitazone—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0134	0.0266	CbGbCtD
Rosiglitazone—ALB—Rufinamide—epilepsy syndrome	0.0133	0.0264	CbGbCtD
Rosiglitazone—PTGS1—Diazepam—epilepsy syndrome	0.0132	0.0261	CbGbCtD
Rosiglitazone—CYP2C19—Felbamate—epilepsy syndrome	0.0124	0.0247	CbGbCtD
Rosiglitazone—CYP2C19—Trimethadione—epilepsy syndrome	0.0124	0.0247	CbGbCtD
Rosiglitazone—CYP2A6—Valproic Acid—epilepsy syndrome	0.0121	0.0241	CbGbCtD
Rosiglitazone—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0117	0.0232	CbGbCtD
Rosiglitazone—ALB—Phenytoin—epilepsy syndrome	0.0116	0.0231	CbGbCtD
Rosiglitazone—ALB—Propofol—epilepsy syndrome	0.0108	0.0215	CbGbCtD
Rosiglitazone—PTGS1—Valproic Acid—epilepsy syndrome	0.0104	0.0206	CbGbCtD
Rosiglitazone—CYP2C9—Trimethadione—epilepsy syndrome	0.0103	0.0205	CbGbCtD
Rosiglitazone—CYP2C19—Clobazam—epilepsy syndrome	0.0101	0.0201	CbGbCtD
Rosiglitazone—CYP2C8—Carbamazepine—epilepsy syndrome	0.01	0.0199	CbGbCtD
Rosiglitazone—ALB—Diazepam—epilepsy syndrome	0.00983	0.0195	CbGbCtD
Rosiglitazone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00973	0.0193	CbGbCtD
Rosiglitazone—CYP2C8—Primidone—epilepsy syndrome	0.00936	0.0186	CbGbCtD
Rosiglitazone—CYP2C8—Phenytoin—epilepsy syndrome	0.00899	0.0178	CbGbCtD
Rosiglitazone—CYP2C19—Carbamazepine—epilepsy syndrome	0.00841	0.0167	CbGbCtD
Rosiglitazone—CYP2C8—Propofol—epilepsy syndrome	0.00838	0.0166	CbGbCtD
Rosiglitazone—CYP2C8—Phenobarbital—epilepsy syndrome	0.00801	0.0159	CbGbCtD
Rosiglitazone—CYP2C19—Primidone—epilepsy syndrome	0.00785	0.0156	CbGbCtD
Rosiglitazone—CYP1A2—Carbamazepine—epilepsy syndrome	0.00776	0.0154	CbGbCtD
Rosiglitazone—CYP2C8—Diazepam—epilepsy syndrome	0.00759	0.0151	CbGbCtD
Rosiglitazone—CYP2C19—Phenytoin—epilepsy syndrome	0.00754	0.015	CbGbCtD
Rosiglitazone—CYP1A2—Primidone—epilepsy syndrome	0.00724	0.0144	CbGbCtD
Rosiglitazone—CYP2C19—Propofol—epilepsy syndrome	0.00703	0.014	CbGbCtD
Rosiglitazone—CYP2C9—Carbamazepine—epilepsy syndrome	0.00699	0.0139	CbGbCtD
Rosiglitazone—CYP2C19—Phenobarbital—epilepsy syndrome	0.00672	0.0133	CbGbCtD
Rosiglitazone—CYP2C9—Primidone—epilepsy syndrome	0.00653	0.013	CbGbCtD
Rosiglitazone—CYP1A2—Propofol—epilepsy syndrome	0.00649	0.0129	CbGbCtD
Rosiglitazone—CYP2C19—Diazepam—epilepsy syndrome	0.00637	0.0126	CbGbCtD
Rosiglitazone—CYP2C9—Phenytoin—epilepsy syndrome	0.00627	0.0124	CbGbCtD
Rosiglitazone—CYP2C19—Zonisamide—epilepsy syndrome	0.00622	0.0123	CbGbCtD
Rosiglitazone—CYP1A2—Phenobarbital—epilepsy syndrome	0.0062	0.0123	CbGbCtD
Rosiglitazone—CYP2C8—Valproic Acid—epilepsy syndrome	0.00599	0.0119	CbGbCtD
Rosiglitazone—CYP1A2—Diazepam—epilepsy syndrome	0.00588	0.0117	CbGbCtD
Rosiglitazone—CYP2C9—Propofol—epilepsy syndrome	0.00585	0.0116	CbGbCtD
Rosiglitazone—CYP2C9—Phenobarbital—epilepsy syndrome	0.00559	0.0111	CbGbCtD
Rosiglitazone—CYP2D6—Propofol—epilepsy syndrome	0.00535	0.0106	CbGbCtD
Rosiglitazone—CYP2C9—Diazepam—epilepsy syndrome	0.0053	0.0105	CbGbCtD
Rosiglitazone—CYP2C19—Valproic Acid—epilepsy syndrome	0.00502	0.00997	CbGbCtD
Rosiglitazone—CYP1A2—Valproic Acid—epilepsy syndrome	0.00463	0.0092	CbGbCtD
Rosiglitazone—CYP2C19—Topiramate—epilepsy syndrome	0.00453	0.009	CbGbCtD
Rosiglitazone—CYP2C9—Valproic Acid—epilepsy syndrome	0.00418	0.00829	CbGbCtD
Rosiglitazone—PPARG—forelimb—epilepsy syndrome	0.00166	0.154	CbGeAlD
Rosiglitazone—ACSL4—forebrain—epilepsy syndrome	0.000839	0.0777	CbGeAlD
Rosiglitazone—Pioglitazone—CYP2C19—epilepsy syndrome	0.000657	0.412	CrCbGaD
Rosiglitazone—ACSL4—medulla oblongata—epilepsy syndrome	0.000606	0.0561	CbGeAlD
Rosiglitazone—ACSL4—midbrain—epilepsy syndrome	0.000554	0.0513	CbGeAlD
Rosiglitazone—ACSL4—spinal cord—epilepsy syndrome	0.00054	0.0501	CbGeAlD
Rosiglitazone—Pioglitazone—CYP2D6—epilepsy syndrome	0.000487	0.305	CrCbGaD
Rosiglitazone—PTGS1—ganglion—epilepsy syndrome	0.000481	0.0446	CbGeAlD
Rosiglitazone—ACSL4—head—epilepsy syndrome	0.00048	0.0445	CbGeAlD
Rosiglitazone—ACSL4—nervous system—epilepsy syndrome	0.000455	0.0422	CbGeAlD
Rosiglitazone—ACSL4—central nervous system—epilepsy syndrome	0.000438	0.0406	CbGeAlD
Rosiglitazone—ACSL4—cerebellum—epilepsy syndrome	0.000428	0.0397	CbGeAlD
Rosiglitazone—PPARG—forebrain—epilepsy syndrome	0.000377	0.035	CbGeAlD
Rosiglitazone—ACSL4—brain—epilepsy syndrome	0.000348	0.0322	CbGeAlD
Rosiglitazone—CYP2D6—hindbrain—epilepsy syndrome	0.0003	0.0278	CbGeAlD
Rosiglitazone—Mepyramine—CYP2D6—epilepsy syndrome	0.000235	0.147	CrCbGaD
Rosiglitazone—CYP2A6—cerebellum—epilepsy syndrome	0.000226	0.021	CbGeAlD
Rosiglitazone—Tripelennamine—CYP2D6—epilepsy syndrome	0.000217	0.136	CrCbGaD
Rosiglitazone—PPARG—head—epilepsy syndrome	0.000216	0.02	CbGeAlD
Rosiglitazone—PPARG—nervous system—epilepsy syndrome	0.000205	0.019	CbGeAlD
Rosiglitazone—PTGS1—forebrain—epilepsy syndrome	0.000202	0.0187	CbGeAlD
Rosiglitazone—PPARG—central nervous system—epilepsy syndrome	0.000197	0.0183	CbGeAlD
Rosiglitazone—PTGS1—telencephalon—epilepsy syndrome	0.000185	0.0172	CbGeAlD
Rosiglitazone—CYP2A6—brain—epilepsy syndrome	0.000184	0.017	CbGeAlD
Rosiglitazone—CYP2D6—brainstem—epilepsy syndrome	0.000172	0.0159	CbGeAlD
Rosiglitazone—CYP2D6—forebrain—epilepsy syndrome	0.000166	0.0154	CbGeAlD
Rosiglitazone—PPARG—brain—epilepsy syndrome	0.000157	0.0145	CbGeAlD
Rosiglitazone—CYP2D6—telencephalon—epilepsy syndrome	0.000152	0.0141	CbGeAlD
Rosiglitazone—ALB—brain—epilepsy syndrome	0.000147	0.0136	CbGeAlD
Rosiglitazone—PTGS1—spinal cord—epilepsy syndrome	0.00013	0.012	CbGeAlD
Rosiglitazone—PTGS1—head—epilepsy syndrome	0.000115	0.0107	CbGeAlD
Rosiglitazone—PTGS1—nervous system—epilepsy syndrome	0.000109	0.0101	CbGeAlD
Rosiglitazone—Eye disorder—Pregabalin—epilepsy syndrome	0.000106	0.00075	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000106	0.000749	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000106	0.000748	CcSEcCtD
Rosiglitazone—Back pain—Valproic Acid—epilepsy syndrome	0.000106	0.000748	CcSEcCtD
Rosiglitazone—Fatigue—Clonazepam—epilepsy syndrome	0.000106	0.000747	CcSEcCtD
Rosiglitazone—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000106	0.000745	CcSEcCtD
Rosiglitazone—Asthenia—Midazolam—epilepsy syndrome	0.000105	0.000745	CcSEcCtD
Rosiglitazone—PTGS1—central nervous system—epilepsy syndrome	0.000105	0.00977	CbGeAlD
Rosiglitazone—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000105	0.000743	CcSEcCtD
Rosiglitazone—Fatigue—Phenytoin—epilepsy syndrome	0.000105	0.000742	CcSEcCtD
Rosiglitazone—Constipation—Clonazepam—epilepsy syndrome	0.000105	0.000741	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000105	0.000739	CcSEcCtD
Rosiglitazone—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000105	0.000738	CcSEcCtD
Rosiglitazone—Hepatitis—Gabapentin—epilepsy syndrome	0.000104	0.000736	CcSEcCtD
Rosiglitazone—Constipation—Phenytoin—epilepsy syndrome	0.000104	0.000736	CcSEcCtD
Rosiglitazone—Asthenia—Levetiracetam—epilepsy syndrome	0.000104	0.000735	CcSEcCtD
Rosiglitazone—Pruritus—Midazolam—epilepsy syndrome	0.000104	0.000734	CcSEcCtD
Rosiglitazone—Constipation—Oxcarbazepine—epilepsy syndrome	0.000104	0.000732	CcSEcCtD
Rosiglitazone—Urticaria—Felbamate—epilepsy syndrome	0.000103	0.00073	CcSEcCtD
Rosiglitazone—CYP2C8—brain—epilepsy syndrome	0.000103	0.00956	CbGeAlD
Rosiglitazone—Diarrhoea—Propofol—epilepsy syndrome	0.000103	0.000726	CcSEcCtD
Rosiglitazone—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000103	0.000725	CcSEcCtD
Rosiglitazone—Immune system disorder—Pregabalin—epilepsy syndrome	0.000103	0.000725	CcSEcCtD
Rosiglitazone—Pruritus—Levetiracetam—epilepsy syndrome	0.000103	0.000725	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000102	0.000724	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000102	0.000724	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000102	0.000719	CcSEcCtD
Rosiglitazone—Headache—Acetazolamide—epilepsy syndrome	0.000101	0.000715	CcSEcCtD
Rosiglitazone—Anaemia—Valproic Acid—epilepsy syndrome	0.000101	0.000715	CcSEcCtD
Rosiglitazone—Urticaria—Zonisamide—epilepsy syndrome	0.000101	0.000714	CcSEcCtD
Rosiglitazone—Asthenia—Fosphenytoin—epilepsy syndrome	0.000101	0.00071	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.0001	0.000709	CcSEcCtD
Rosiglitazone—Fatigue—Carbamazepine—epilepsy syndrome	0.0001	0.000708	CcSEcCtD
Rosiglitazone—Angioedema—Valproic Acid—epilepsy syndrome	0.0001	0.000707	CcSEcCtD
Rosiglitazone—Weight increased—Topiramate—epilepsy syndrome	9.98e-05	0.000704	CcSEcCtD
Rosiglitazone—Constipation—Carbamazepine—epilepsy syndrome	9.95e-05	0.000703	CcSEcCtD
Rosiglitazone—Dizziness—Propofol—epilepsy syndrome	9.94e-05	0.000701	CcSEcCtD
Rosiglitazone—Diarrhoea—Levetiracetam—epilepsy syndrome	9.93e-05	0.000701	CcSEcCtD
Rosiglitazone—Pruritus—Fosphenytoin—epilepsy syndrome	9.91e-05	0.0007	CcSEcCtD
Rosiglitazone—Malnutrition—Pregabalin—epilepsy syndrome	9.9e-05	0.000699	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Topiramate—epilepsy syndrome	9.89e-05	0.000698	CcSEcCtD
Rosiglitazone—Erythema multiforme—Gabapentin—epilepsy syndrome	9.86e-05	0.000696	CcSEcCtD
Rosiglitazone—Leukopenia—Valproic Acid—epilepsy syndrome	9.8e-05	0.000692	CcSEcCtD
Rosiglitazone—Asthenia—Vigabatrin—epilepsy syndrome	9.8e-05	0.000692	CcSEcCtD
Rosiglitazone—Urticaria—Clonazepam—epilepsy syndrome	9.75e-05	0.000688	CcSEcCtD
Rosiglitazone—Eye disorder—Gabapentin—epilepsy syndrome	9.75e-05	0.000688	CcSEcCtD
Rosiglitazone—Dizziness—Midazolam—epilepsy syndrome	9.72e-05	0.000686	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	9.71e-05	0.000686	CcSEcCtD
Rosiglitazone—Fatigue—Lamotrigine—epilepsy syndrome	9.7e-05	0.000685	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	9.69e-05	0.000684	CcSEcCtD
Rosiglitazone—Urticaria—Phenytoin—epilepsy syndrome	9.69e-05	0.000684	CcSEcCtD
Rosiglitazone—Cardiac disorder—Gabapentin—epilepsy syndrome	9.68e-05	0.000683	CcSEcCtD
Rosiglitazone—Pruritus—Vigabatrin—epilepsy syndrome	9.66e-05	0.000682	CcSEcCtD
Rosiglitazone—Asthenia—Diazepam—epilepsy syndrome	9.65e-05	0.000681	CcSEcCtD
Rosiglitazone—Urticaria—Oxcarbazepine—epilepsy syndrome	9.64e-05	0.00068	CcSEcCtD
Rosiglitazone—Constipation—Lamotrigine—epilepsy syndrome	9.62e-05	0.000679	CcSEcCtD
Rosiglitazone—Nausea—Acetazolamide—epilepsy syndrome	9.61e-05	0.000678	CcSEcCtD
Rosiglitazone—Dizziness—Levetiracetam—epilepsy syndrome	9.6e-05	0.000678	CcSEcCtD
Rosiglitazone—Diarrhoea—Fosphenytoin—epilepsy syndrome	9.59e-05	0.000677	CcSEcCtD
Rosiglitazone—Back pain—Pregabalin—epilepsy syndrome	9.58e-05	0.000676	CcSEcCtD
Rosiglitazone—Pruritus—Diazepam—epilepsy syndrome	9.51e-05	0.000672	CcSEcCtD
Rosiglitazone—CYP2D6—head—epilepsy syndrome	9.49e-05	0.0088	CbGeAlD
Rosiglitazone—Rash—Propofol—epilepsy syndrome	9.47e-05	0.000669	CcSEcCtD
Rosiglitazone—Dermatitis—Propofol—epilepsy syndrome	9.46e-05	0.000668	CcSEcCtD
Rosiglitazone—Hypertension—Valproic Acid—epilepsy syndrome	9.46e-05	0.000668	CcSEcCtD
Rosiglitazone—Immune system disorder—Gabapentin—epilepsy syndrome	9.42e-05	0.000665	CcSEcCtD
Rosiglitazone—Headache—Propofol—epilepsy syndrome	9.41e-05	0.000665	CcSEcCtD
Rosiglitazone—Diarrhoea—Vigabatrin—epilepsy syndrome	9.34e-05	0.00066	CcSEcCtD
Rosiglitazone—Asthenia—Felbamate—epilepsy syndrome	9.34e-05	0.000659	CcSEcCtD
Rosiglitazone—Myalgia—Valproic Acid—epilepsy syndrome	9.32e-05	0.000658	CcSEcCtD
Rosiglitazone—Arthralgia—Valproic Acid—epilepsy syndrome	9.32e-05	0.000658	CcSEcCtD
Rosiglitazone—Rash—Midazolam—epilepsy syndrome	9.27e-05	0.000654	CcSEcCtD
Rosiglitazone—Dizziness—Fosphenytoin—epilepsy syndrome	9.26e-05	0.000654	CcSEcCtD
Rosiglitazone—Dermatitis—Midazolam—epilepsy syndrome	9.26e-05	0.000654	CcSEcCtD
Rosiglitazone—Urticaria—Carbamazepine—epilepsy syndrome	9.25e-05	0.000653	CcSEcCtD
Rosiglitazone—Headache—Midazolam—epilepsy syndrome	9.21e-05	0.00065	CcSEcCtD
Rosiglitazone—Pruritus—Felbamate—epilepsy syndrome	9.21e-05	0.00065	CcSEcCtD
Rosiglitazone—Diarrhoea—Diazepam—epilepsy syndrome	9.2e-05	0.000649	CcSEcCtD
Rosiglitazone—Sinusitis—Topiramate—epilepsy syndrome	9.17e-05	0.000647	CcSEcCtD
Rosiglitazone—Rash—Levetiracetam—epilepsy syndrome	9.15e-05	0.000646	CcSEcCtD
Rosiglitazone—Anaemia—Pregabalin—epilepsy syndrome	9.15e-05	0.000646	CcSEcCtD
Rosiglitazone—Dermatitis—Levetiracetam—epilepsy syndrome	9.14e-05	0.000646	CcSEcCtD
Rosiglitazone—Asthenia—Zonisamide—epilepsy syndrome	9.14e-05	0.000645	CcSEcCtD
Rosiglitazone—Headache—Levetiracetam—epilepsy syndrome	9.09e-05	0.000642	CcSEcCtD
Rosiglitazone—Malnutrition—Gabapentin—epilepsy syndrome	9.08e-05	0.000641	CcSEcCtD
Rosiglitazone—Angioedema—Pregabalin—epilepsy syndrome	9.05e-05	0.000639	CcSEcCtD
Rosiglitazone—Dizziness—Vigabatrin—epilepsy syndrome	9.03e-05	0.000638	CcSEcCtD
Rosiglitazone—Pruritus—Zonisamide—epilepsy syndrome	9.01e-05	0.000636	CcSEcCtD
Rosiglitazone—CYP2D6—nervous system—epilepsy syndrome	9e-05	0.00834	CbGeAlD
Rosiglitazone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.94e-05	0.000631	CcSEcCtD
Rosiglitazone—Oedema—Valproic Acid—epilepsy syndrome	8.94e-05	0.000631	CcSEcCtD
Rosiglitazone—Urticaria—Lamotrigine—epilepsy syndrome	8.94e-05	0.000631	CcSEcCtD
Rosiglitazone—Nausea—Propofol—epilepsy syndrome	8.92e-05	0.00063	CcSEcCtD
Rosiglitazone—Diarrhoea—Felbamate—epilepsy syndrome	8.9e-05	0.000629	CcSEcCtD
Rosiglitazone—Dizziness—Diazepam—epilepsy syndrome	8.89e-05	0.000628	CcSEcCtD
Rosiglitazone—Infection—Valproic Acid—epilepsy syndrome	8.88e-05	0.000627	CcSEcCtD
Rosiglitazone—Leukopenia—Pregabalin—epilepsy syndrome	8.86e-05	0.000626	CcSEcCtD
Rosiglitazone—Rash—Fosphenytoin—epilepsy syndrome	8.83e-05	0.000624	CcSEcCtD
Rosiglitazone—Dermatitis—Fosphenytoin—epilepsy syndrome	8.83e-05	0.000623	CcSEcCtD
Rosiglitazone—Asthenia—Clonazepam—epilepsy syndrome	8.81e-05	0.000622	CcSEcCtD
Rosiglitazone—Back pain—Gabapentin—epilepsy syndrome	8.78e-05	0.00062	CcSEcCtD
Rosiglitazone—Headache—Fosphenytoin—epilepsy syndrome	8.78e-05	0.00062	CcSEcCtD
Rosiglitazone—Hepatitis—Topiramate—epilepsy syndrome	8.77e-05	0.00062	CcSEcCtD
Rosiglitazone—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.77e-05	0.000619	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.75e-05	0.000618	CcSEcCtD
Rosiglitazone—Asthenia—Phenytoin—epilepsy syndrome	8.75e-05	0.000618	CcSEcCtD
Rosiglitazone—Nausea—Midazolam—epilepsy syndrome	8.73e-05	0.000616	CcSEcCtD
Rosiglitazone—Diarrhoea—Zonisamide—epilepsy syndrome	8.71e-05	0.000615	CcSEcCtD
Rosiglitazone—Asthenia—Oxcarbazepine—epilepsy syndrome	8.7e-05	0.000614	CcSEcCtD
Rosiglitazone—Pruritus—Clonazepam—epilepsy syndrome	8.68e-05	0.000613	CcSEcCtD
Rosiglitazone—CYP2D6—central nervous system—epilepsy syndrome	8.66e-05	0.00803	CbGeAlD
Rosiglitazone—Oedema peripheral—Topiramate—epilepsy syndrome	8.64e-05	0.00061	CcSEcCtD
Rosiglitazone—Pruritus—Phenytoin—epilepsy syndrome	8.63e-05	0.000609	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Topiramate—epilepsy syndrome	8.62e-05	0.000609	CcSEcCtD
Rosiglitazone—Nausea—Levetiracetam—epilepsy syndrome	8.62e-05	0.000609	CcSEcCtD
Rosiglitazone—Rash—Vigabatrin—epilepsy syndrome	8.61e-05	0.000608	CcSEcCtD
Rosiglitazone—Dizziness—Felbamate—epilepsy syndrome	8.6e-05	0.000607	CcSEcCtD
Rosiglitazone—Dermatitis—Vigabatrin—epilepsy syndrome	8.6e-05	0.000607	CcSEcCtD
Rosiglitazone—Pruritus—Oxcarbazepine—epilepsy syndrome	8.58e-05	0.000606	CcSEcCtD
Rosiglitazone—Headache—Vigabatrin—epilepsy syndrome	8.55e-05	0.000604	CcSEcCtD
Rosiglitazone—Hypertension—Pregabalin—epilepsy syndrome	8.55e-05	0.000604	CcSEcCtD
Rosiglitazone—Rash—Diazepam—epilepsy syndrome	8.48e-05	0.000598	CcSEcCtD
Rosiglitazone—Dermatitis—Diazepam—epilepsy syndrome	8.47e-05	0.000598	CcSEcCtD
Rosiglitazone—CYP2D6—cerebellum—epilepsy syndrome	8.47e-05	0.00785	CbGeAlD
Rosiglitazone—Arthralgia—Pregabalin—epilepsy syndrome	8.43e-05	0.000595	CcSEcCtD
Rosiglitazone—Myalgia—Pregabalin—epilepsy syndrome	8.43e-05	0.000595	CcSEcCtD
Rosiglitazone—Dizziness—Zonisamide—epilepsy syndrome	8.42e-05	0.000595	CcSEcCtD
Rosiglitazone—Headache—Diazepam—epilepsy syndrome	8.42e-05	0.000595	CcSEcCtD
Rosiglitazone—Diarrhoea—Clonazepam—epilepsy syndrome	8.4e-05	0.000593	CcSEcCtD
Rosiglitazone—Anaemia—Gabapentin—epilepsy syndrome	8.39e-05	0.000592	CcSEcCtD
Rosiglitazone—PTGS1—brain—epilepsy syndrome	8.37e-05	0.00776	CbGeAlD
Rosiglitazone—Asthenia—Carbamazepine—epilepsy syndrome	8.35e-05	0.00059	CcSEcCtD
Rosiglitazone—Diarrhoea—Phenytoin—epilepsy syndrome	8.34e-05	0.000589	CcSEcCtD
Rosiglitazone—Nausea—Fosphenytoin—epilepsy syndrome	8.32e-05	0.000588	CcSEcCtD
Rosiglitazone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.3e-05	0.000586	CcSEcCtD
Rosiglitazone—Erythema multiforme—Topiramate—epilepsy syndrome	8.3e-05	0.000586	CcSEcCtD
Rosiglitazone—Angioedema—Gabapentin—epilepsy syndrome	8.3e-05	0.000586	CcSEcCtD
Rosiglitazone—Pruritus—Carbamazepine—epilepsy syndrome	8.23e-05	0.000581	CcSEcCtD
Rosiglitazone—Rash—Felbamate—epilepsy syndrome	8.2e-05	0.000579	CcSEcCtD
Rosiglitazone—Eye disorder—Topiramate—epilepsy syndrome	8.2e-05	0.000579	CcSEcCtD
Rosiglitazone—Dermatitis—Felbamate—epilepsy syndrome	8.2e-05	0.000579	CcSEcCtD
Rosiglitazone—Headache—Felbamate—epilepsy syndrome	8.15e-05	0.000576	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.14e-05	0.000575	CcSEcCtD
Rosiglitazone—Cardiac disorder—Topiramate—epilepsy syndrome	8.14e-05	0.000575	CcSEcCtD
Rosiglitazone—Leukopenia—Gabapentin—epilepsy syndrome	8.13e-05	0.000574	CcSEcCtD
Rosiglitazone—Dizziness—Clonazepam—epilepsy syndrome	8.12e-05	0.000573	CcSEcCtD
Rosiglitazone—Nausea—Vigabatrin—epilepsy syndrome	8.11e-05	0.000573	CcSEcCtD
Rosiglitazone—Oedema—Pregabalin—epilepsy syndrome	8.08e-05	0.000571	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.08e-05	0.000571	CcSEcCtD
Rosiglitazone—Asthenia—Lamotrigine—epilepsy syndrome	8.07e-05	0.00057	CcSEcCtD
Rosiglitazone—Dizziness—Phenytoin—epilepsy syndrome	8.06e-05	0.000569	CcSEcCtD
Rosiglitazone—Rash—Zonisamide—epilepsy syndrome	8.03e-05	0.000567	CcSEcCtD
Rosiglitazone—Infection—Pregabalin—epilepsy syndrome	8.03e-05	0.000567	CcSEcCtD
Rosiglitazone—Dermatitis—Zonisamide—epilepsy syndrome	8.02e-05	0.000566	CcSEcCtD
Rosiglitazone—Dizziness—Oxcarbazepine—epilepsy syndrome	8.02e-05	0.000566	CcSEcCtD
Rosiglitazone—Nausea—Diazepam—epilepsy syndrome	7.99e-05	0.000564	CcSEcCtD
Rosiglitazone—Headache—Zonisamide—epilepsy syndrome	7.98e-05	0.000563	CcSEcCtD
Rosiglitazone—Diarrhoea—Carbamazepine—epilepsy syndrome	7.96e-05	0.000562	CcSEcCtD
Rosiglitazone—Pruritus—Lamotrigine—epilepsy syndrome	7.96e-05	0.000562	CcSEcCtD
Rosiglitazone—Immune system disorder—Topiramate—epilepsy syndrome	7.93e-05	0.00056	CcSEcCtD
Rosiglitazone—Nervous system disorder—Pregabalin—epilepsy syndrome	7.92e-05	0.000559	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.91e-05	0.000559	CcSEcCtD
Rosiglitazone—Hypertension—Gabapentin—epilepsy syndrome	7.84e-05	0.000553	CcSEcCtD
Rosiglitazone—Rash—Clonazepam—epilepsy syndrome	7.74e-05	0.000546	CcSEcCtD
Rosiglitazone—Dermatitis—Clonazepam—epilepsy syndrome	7.73e-05	0.000546	CcSEcCtD
Rosiglitazone—Arthralgia—Gabapentin—epilepsy syndrome	7.73e-05	0.000546	CcSEcCtD
Rosiglitazone—Myalgia—Gabapentin—epilepsy syndrome	7.73e-05	0.000546	CcSEcCtD
Rosiglitazone—Nausea—Felbamate—epilepsy syndrome	7.73e-05	0.000546	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.72e-05	0.000545	CcSEcCtD
Rosiglitazone—Fatigue—Valproic Acid—epilepsy syndrome	7.71e-05	0.000544	CcSEcCtD
Rosiglitazone—Dizziness—Carbamazepine—epilepsy syndrome	7.7e-05	0.000543	CcSEcCtD
Rosiglitazone—Diarrhoea—Lamotrigine—epilepsy syndrome	7.7e-05	0.000543	CcSEcCtD
Rosiglitazone—Headache—Clonazepam—epilepsy syndrome	7.69e-05	0.000543	CcSEcCtD
Rosiglitazone—Rash—Phenytoin—epilepsy syndrome	7.69e-05	0.000543	CcSEcCtD
Rosiglitazone—Dermatitis—Phenytoin—epilepsy syndrome	7.68e-05	0.000542	CcSEcCtD
Rosiglitazone—Rash—Oxcarbazepine—epilepsy syndrome	7.65e-05	0.00054	CcSEcCtD
Rosiglitazone—Constipation—Valproic Acid—epilepsy syndrome	7.64e-05	0.00054	CcSEcCtD
Rosiglitazone—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.64e-05	0.000539	CcSEcCtD
Rosiglitazone—Headache—Phenytoin—epilepsy syndrome	7.64e-05	0.000539	CcSEcCtD
Rosiglitazone—Malnutrition—Topiramate—epilepsy syndrome	7.64e-05	0.000539	CcSEcCtD
Rosiglitazone—Headache—Oxcarbazepine—epilepsy syndrome	7.6e-05	0.000536	CcSEcCtD
Rosiglitazone—Nausea—Zonisamide—epilepsy syndrome	7.57e-05	0.000534	CcSEcCtD
Rosiglitazone—Dizziness—Lamotrigine—epilepsy syndrome	7.44e-05	0.000525	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.41e-05	0.000523	CcSEcCtD
Rosiglitazone—Oedema—Gabapentin—epilepsy syndrome	7.41e-05	0.000523	CcSEcCtD
Rosiglitazone—Back pain—Topiramate—epilepsy syndrome	7.39e-05	0.000522	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.36e-05	0.00052	CcSEcCtD
Rosiglitazone—Infection—Gabapentin—epilepsy syndrome	7.36e-05	0.00052	CcSEcCtD
Rosiglitazone—Rash—Carbamazepine—epilepsy syndrome	7.34e-05	0.000518	CcSEcCtD
Rosiglitazone—Dermatitis—Carbamazepine—epilepsy syndrome	7.33e-05	0.000518	CcSEcCtD
Rosiglitazone—Nausea—Clonazepam—epilepsy syndrome	7.29e-05	0.000515	CcSEcCtD
Rosiglitazone—Headache—Carbamazepine—epilepsy syndrome	7.29e-05	0.000515	CcSEcCtD
Rosiglitazone—Nervous system disorder—Gabapentin—epilepsy syndrome	7.27e-05	0.000513	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.26e-05	0.000512	CcSEcCtD
Rosiglitazone—Nausea—Phenytoin—epilepsy syndrome	7.24e-05	0.000511	CcSEcCtD
Rosiglitazone—Nausea—Oxcarbazepine—epilepsy syndrome	7.2e-05	0.000509	CcSEcCtD
Rosiglitazone—Urticaria—Valproic Acid—epilepsy syndrome	7.1e-05	0.000501	CcSEcCtD
Rosiglitazone—Rash—Lamotrigine—epilepsy syndrome	7.09e-05	0.000501	CcSEcCtD
Rosiglitazone—Dermatitis—Lamotrigine—epilepsy syndrome	7.09e-05	0.0005	CcSEcCtD
Rosiglitazone—Anaemia—Topiramate—epilepsy syndrome	7.06e-05	0.000498	CcSEcCtD
Rosiglitazone—Headache—Lamotrigine—epilepsy syndrome	7.05e-05	0.000498	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.98e-05	0.000493	CcSEcCtD
Rosiglitazone—Fatigue—Pregabalin—epilepsy syndrome	6.97e-05	0.000492	CcSEcCtD
Rosiglitazone—Nausea—Carbamazepine—epilepsy syndrome	6.91e-05	0.000488	CcSEcCtD
Rosiglitazone—Constipation—Pregabalin—epilepsy syndrome	6.91e-05	0.000488	CcSEcCtD
Rosiglitazone—CYP2D6—brain—epilepsy syndrome	6.88e-05	0.00637	CbGeAlD
Rosiglitazone—Leukopenia—Topiramate—epilepsy syndrome	6.84e-05	0.000483	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.75e-05	0.000477	CcSEcCtD
Rosiglitazone—Nausea—Lamotrigine—epilepsy syndrome	6.68e-05	0.000472	CcSEcCtD
Rosiglitazone—Hypertension—Topiramate—epilepsy syndrome	6.59e-05	0.000466	CcSEcCtD
Rosiglitazone—Myalgia—Topiramate—epilepsy syndrome	6.5e-05	0.000459	CcSEcCtD
Rosiglitazone—Arthralgia—Topiramate—epilepsy syndrome	6.5e-05	0.000459	CcSEcCtD
Rosiglitazone—Urticaria—Pregabalin—epilepsy syndrome	6.42e-05	0.000453	CcSEcCtD
Rosiglitazone—Asthenia—Valproic Acid—epilepsy syndrome	6.41e-05	0.000453	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.4e-05	0.000452	CcSEcCtD
Rosiglitazone—Fatigue—Gabapentin—epilepsy syndrome	6.39e-05	0.000451	CcSEcCtD
Rosiglitazone—Constipation—Gabapentin—epilepsy syndrome	6.34e-05	0.000447	CcSEcCtD
Rosiglitazone—Pruritus—Valproic Acid—epilepsy syndrome	6.32e-05	0.000446	CcSEcCtD
Rosiglitazone—Oedema—Topiramate—epilepsy syndrome	6.23e-05	0.00044	CcSEcCtD
Rosiglitazone—Infection—Topiramate—epilepsy syndrome	6.19e-05	0.000437	CcSEcCtD
Rosiglitazone—Diarrhoea—Valproic Acid—epilepsy syndrome	6.12e-05	0.000432	CcSEcCtD
Rosiglitazone—Nervous system disorder—Topiramate—epilepsy syndrome	6.11e-05	0.000432	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Topiramate—epilepsy syndrome	6.1e-05	0.000431	CcSEcCtD
Rosiglitazone—Dizziness—Valproic Acid—epilepsy syndrome	5.91e-05	0.000417	CcSEcCtD
Rosiglitazone—Urticaria—Gabapentin—epilepsy syndrome	5.89e-05	0.000416	CcSEcCtD
Rosiglitazone—Asthenia—Pregabalin—epilepsy syndrome	5.8e-05	0.000409	CcSEcCtD
Rosiglitazone—Pruritus—Pregabalin—epilepsy syndrome	5.72e-05	0.000404	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.68e-05	0.000401	CcSEcCtD
Rosiglitazone—Rash—Valproic Acid—epilepsy syndrome	5.64e-05	0.000398	CcSEcCtD
Rosiglitazone—Dermatitis—Valproic Acid—epilepsy syndrome	5.63e-05	0.000398	CcSEcCtD
Rosiglitazone—Headache—Valproic Acid—epilepsy syndrome	5.6e-05	0.000395	CcSEcCtD
Rosiglitazone—Diarrhoea—Pregabalin—epilepsy syndrome	5.53e-05	0.00039	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.38e-05	0.00038	CcSEcCtD
Rosiglitazone—Fatigue—Topiramate—epilepsy syndrome	5.37e-05	0.000379	CcSEcCtD
Rosiglitazone—Dizziness—Pregabalin—epilepsy syndrome	5.34e-05	0.000377	CcSEcCtD
Rosiglitazone—Constipation—Topiramate—epilepsy syndrome	5.33e-05	0.000376	CcSEcCtD
Rosiglitazone—Asthenia—Gabapentin—epilepsy syndrome	5.32e-05	0.000375	CcSEcCtD
Rosiglitazone—Nausea—Valproic Acid—epilepsy syndrome	5.31e-05	0.000375	CcSEcCtD
Rosiglitazone—Pruritus—Gabapentin—epilepsy syndrome	5.24e-05	0.00037	CcSEcCtD
Rosiglitazone—Rash—Pregabalin—epilepsy syndrome	5.1e-05	0.00036	CcSEcCtD
Rosiglitazone—Dermatitis—Pregabalin—epilepsy syndrome	5.09e-05	0.000359	CcSEcCtD
Rosiglitazone—Diarrhoea—Gabapentin—epilepsy syndrome	5.07e-05	0.000358	CcSEcCtD
Rosiglitazone—Headache—Pregabalin—epilepsy syndrome	5.06e-05	0.000357	CcSEcCtD
Rosiglitazone—Urticaria—Topiramate—epilepsy syndrome	4.95e-05	0.00035	CcSEcCtD
Rosiglitazone—Dizziness—Gabapentin—epilepsy syndrome	4.9e-05	0.000346	CcSEcCtD
Rosiglitazone—Nausea—Pregabalin—epilepsy syndrome	4.8e-05	0.000339	CcSEcCtD
Rosiglitazone—Rash—Gabapentin—epilepsy syndrome	4.67e-05	0.00033	CcSEcCtD
Rosiglitazone—Dermatitis—Gabapentin—epilepsy syndrome	4.67e-05	0.00033	CcSEcCtD
Rosiglitazone—Headache—Gabapentin—epilepsy syndrome	4.64e-05	0.000328	CcSEcCtD
Rosiglitazone—Asthenia—Topiramate—epilepsy syndrome	4.47e-05	0.000316	CcSEcCtD
Rosiglitazone—Pruritus—Topiramate—epilepsy syndrome	4.41e-05	0.000311	CcSEcCtD
Rosiglitazone—Nausea—Gabapentin—epilepsy syndrome	4.4e-05	0.000311	CcSEcCtD
Rosiglitazone—Diarrhoea—Topiramate—epilepsy syndrome	4.27e-05	0.000301	CcSEcCtD
Rosiglitazone—Dizziness—Topiramate—epilepsy syndrome	4.12e-05	0.000291	CcSEcCtD
Rosiglitazone—Rash—Topiramate—epilepsy syndrome	3.93e-05	0.000278	CcSEcCtD
Rosiglitazone—Dermatitis—Topiramate—epilepsy syndrome	3.93e-05	0.000277	CcSEcCtD
Rosiglitazone—Headache—Topiramate—epilepsy syndrome	3.91e-05	0.000276	CcSEcCtD
Rosiglitazone—Nausea—Topiramate—epilepsy syndrome	3.7e-05	0.000261	CcSEcCtD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.72e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	6.71e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.69e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.69e-06	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GBE1—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	6.63e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	6.63e-06	0.000107	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	6.62e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.56e-06	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.55e-06	0.000106	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.52e-06	0.000105	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.52e-06	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.49e-06	0.000105	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	6.49e-06	0.000105	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—BCHE—epilepsy syndrome	6.46e-06	0.000104	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GPX1—epilepsy syndrome	6.46e-06	0.000104	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—epilepsy syndrome	6.45e-06	0.000104	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	6.45e-06	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	6.44e-06	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.42e-06	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.29e-06	0.000102	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.28e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.27e-06	0.000101	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLAU—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—epilepsy syndrome	6.23e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	6.18e-06	9.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	6.18e-06	9.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.18e-06	9.97e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	6.16e-06	9.95e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.14e-06	9.91e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CHRM3—epilepsy syndrome	6.14e-06	9.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	6.13e-06	9.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.12e-06	9.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—BCHE—epilepsy syndrome	6.11e-06	9.86e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.1e-06	9.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.1e-06	9.84e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PLCB1—epilepsy syndrome	6.1e-06	9.84e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TH—epilepsy syndrome	6.07e-06	9.8e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.98e-06	9.65e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NT5E—epilepsy syndrome	5.94e-06	9.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALAD—epilepsy syndrome	5.94e-06	9.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.86e-06	9.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	5.83e-06	9.41e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PRKCB—epilepsy syndrome	5.81e-06	9.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.78e-06	9.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	5.76e-06	9.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.75e-06	9.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TH—epilepsy syndrome	5.74e-06	9.27e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS2—epilepsy syndrome	5.74e-06	9.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.73e-06	9.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.72e-06	9.23e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	5.7e-06	9.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	5.67e-06	9.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	5.67e-06	9.15e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AGT—epilepsy syndrome	5.66e-06	9.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.64e-06	9.1e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CAT—epilepsy syndrome	5.62e-06	9.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.61e-06	9.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.6e-06	9.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.56e-06	8.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.55e-06	8.95e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOE—epilepsy syndrome	5.55e-06	8.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	5.47e-06	8.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.44e-06	8.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.34e-06	8.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.33e-06	8.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.23e-06	8.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.13e-06	8.29e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	5.08e-06	8.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.07e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.07e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HMOX1—epilepsy syndrome	5.07e-06	8.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	5.04e-06	8.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.03e-06	8.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.03e-06	8.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.03e-06	8.11e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCG2—epilepsy syndrome	5.01e-06	8.08e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CAT—epilepsy syndrome	5e-06	8.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.91e-06	7.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.89e-06	7.9e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2C19—epilepsy syndrome	4.88e-06	7.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.88e-06	7.87e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—epilepsy syndrome	4.87e-06	7.85e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP11A1—epilepsy syndrome	4.85e-06	7.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.84e-06	7.82e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.81e-06	7.77e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—epilepsy syndrome	4.8e-06	7.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	4.79e-06	7.74e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—epilepsy syndrome	4.77e-06	7.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AQP1—epilepsy syndrome	4.75e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CAT—epilepsy syndrome	4.73e-06	7.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.68e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	4.6e-06	7.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.59e-06	7.4e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.56e-06	7.36e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPX1—epilepsy syndrome	4.52e-06	7.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.49e-06	7.25e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AGT—epilepsy syndrome	4.46e-06	7.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.41e-06	7.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.4e-06	7.1e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.38e-06	7.06e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—epilepsy syndrome	4.37e-06	7.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.35e-06	7.03e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—epilepsy syndrome	4.35e-06	7.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.32e-06	6.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.3e-06	6.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.3e-06	6.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPX1—epilepsy syndrome	4.28e-06	6.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.19e-06	6.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.17e-06	6.74e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.17e-06	6.72e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—BCHE—epilepsy syndrome	4.15e-06	6.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.13e-06	6.67e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.11e-06	6.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.1e-06	6.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.03e-06	6.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4e-06	6.46e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4e-06	6.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.99e-06	6.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.98e-06	6.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.97e-06	6.41e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AGT—epilepsy syndrome	3.97e-06	6.4e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A1—epilepsy syndrome	3.96e-06	6.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.94e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.94e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.94e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.93e-06	6.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TH—epilepsy syndrome	3.92e-06	6.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.92e-06	6.33e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLCB1—epilepsy syndrome	3.92e-06	6.32e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TH—epilepsy syndrome	3.9e-06	6.3e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—epilepsy syndrome	3.89e-06	6.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.86e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.84e-06	6.2e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—epilepsy syndrome	3.8e-06	6.14e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—epilepsy syndrome	3.75e-06	6.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—epilepsy syndrome	3.75e-06	6.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.74e-06	6.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.72e-06	6.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—epilepsy syndrome	3.68e-06	5.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.59e-06	5.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.58e-06	5.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	5.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.51e-06	5.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.5e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TH—epilepsy syndrome	3.5e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.45e-06	5.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.44e-06	5.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.43e-06	5.53e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—epilepsy syndrome	3.42e-06	5.52e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—epilepsy syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.41e-06	5.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.4e-06	5.48e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.39e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.37e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—epilepsy syndrome	3.34e-06	5.39e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.32e-06	5.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.27e-06	5.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.27e-06	5.27e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—epilepsy syndrome	3.26e-06	5.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.24e-06	5.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.23e-06	5.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.23e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TH—epilepsy syndrome	3.22e-06	5.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAT—epilepsy syndrome	3.21e-06	5.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.2e-06	5.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TH—epilepsy syndrome	3.19e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—epilepsy syndrome	3.16e-06	5.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.14e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.14e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—epilepsy syndrome	3.12e-06	5.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.07e-06	4.96e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.06e-06	4.94e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—epilepsy syndrome	3.04e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.99e-06	4.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	4.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.92e-06	4.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.91e-06	4.7e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—epilepsy syndrome	2.91e-06	4.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.9e-06	4.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.88e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—epilepsy syndrome	2.88e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.81e-06	4.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.77e-06	4.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.74e-06	4.42e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TH—epilepsy syndrome	2.73e-06	4.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.69e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.69e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.66e-06	4.3e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.66e-06	4.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.65e-06	4.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.63e-06	4.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.61e-06	4.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.58e-06	4.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.56e-06	4.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.56e-06	4.13e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—epilepsy syndrome	2.55e-06	4.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	2.52e-06	4.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.51e-06	4.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—epilepsy syndrome	2.5e-06	4.03e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—epilepsy syndrome	2.46e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.4e-06	3.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.38e-06	3.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.29e-06	3.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.28e-06	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.25e-06	3.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.24e-06	3.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.19e-06	3.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.16e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—epilepsy syndrome	2.14e-06	3.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—epilepsy syndrome	2.12e-06	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.1e-06	3.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.09e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.06e-06	3.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.04e-06	3.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.03e-06	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.97e-06	3.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.92e-06	3.11e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—epilepsy syndrome	1.91e-06	3.08e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.78e-06	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.77e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.76e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.75e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.75e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	2.78e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	2.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.61e-06	2.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.6e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.54e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.5e-06	2.43e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.5e-06	2.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.41e-06	2.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.4e-06	2.26e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.37e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.34e-06	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.27e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—epilepsy syndrome	8.65e-07	1.4e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—epilepsy syndrome	8.6e-07	1.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.72e-07	1.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.1e-07	1.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.04e-07	1.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.01e-07	9.7e-06	CbGpPWpGaD
